Across TCGA pan-cancer cohorts, LINC02330 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC02330 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher LINC02330 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02330 expression acts as an unfavorable survival marker, although some lineages such as LGG and ESCA show a favorable association.
KICH, STAD, and THCA are the cancer types where LINC02330 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.